Difference between revisions of "Patrick Vallance"
Jump to navigation
Jump to search
m (desc) |
|||
| Line 3: | Line 3: | ||
|intersts=COVID-19/Pandemic, COVID-19/Lockdown | |intersts=COVID-19/Pandemic, COVID-19/Lockdown | ||
|image=Patrick Vallance.jpg | |image=Patrick Vallance.jpg | ||
| + | |description=UK millionaire businessman/physician who in March 2018 moved from Director of GlaxoSmithKline to become the UK/Chief Scientific Adviser, chair of [[Scientific Advisory Group for Emergencies]] | ||
|image_width=330px | |image_width=330px | ||
|companieshouse=https://beta.companieshouse.gov.uk/officers/6PidQee1IEUBM01t0-5pOKLsYTA/appointments | |companieshouse=https://beta.companieshouse.gov.uk/officers/6PidQee1IEUBM01t0-5pOKLsYTA/appointments | ||
| Line 46: | Line 47: | ||
{{FA|Scientific Advisory Group for Emergencies}} | {{FA|Scientific Advisory Group for Emergencies}} | ||
Vallance, as chair of [[Scientific Advisory Group for Emergencies]], was one of very few members who was publicly named. He stated in a letter to the UK parliament in April 2020 that the decision not to disclose its membership was based on advice from the [[Centre for the Protection of National Infrastructure]].<ref>https://www.thenational.scot/news/uk-news/18404964.scientific-advisory-group-emergencies-work/</ref> | Vallance, as chair of [[Scientific Advisory Group for Emergencies]], was one of very few members who was publicly named. He stated in a letter to the UK parliament in April 2020 that the decision not to disclose its membership was based on advice from the [[Centre for the Protection of National Infrastructure]].<ref>https://www.thenational.scot/news/uk-news/18404964.scientific-advisory-group-emergencies-work/</ref> | ||
| − | |||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
Revision as of 20:42, 22 November 2020
 Patrick Vallance     (physician, scientist, pharmacologist, millionaire, businessman) | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | |||||||||||||||||||||||||||||||||||||||
| Nationality | UK | ||||||||||||||||||||||||||||||||||||||
| Alma mater | St George's University of London | ||||||||||||||||||||||||||||||||||||||
| Founder of | UK Vaccine Task Force | ||||||||||||||||||||||||||||||||||||||
| Member of | Scientific Advisory Group for Emergencies, Tony Blair Institute for Global Change | ||||||||||||||||||||||||||||||||||||||
UK millionaire businessman/physician who in March 2018 moved from Director of GlaxoSmithKline to become the UK/Chief Scientific Adviser, chair of Scientific Advisory Group for Emergencies
| |||||||||||||||||||||||||||||||||||||||
Sir Patrick John Thompson Vallance FRS FMedSci FRCP is a UK businessman/physician who in March 2018 moved from Director of GlaxoSmithKline to become the UK/Chief Scientific Adviser.
Contents
Career
Big pharma until March 2018.
- Full article: COVID-19/Lockdown
- Full article: COVID-19/Lockdown
In mid March 2020 Vallance "defended the government’s approach to tackling the coronavirus, saying it could have the benefit of creating “herd immunity” across the population."[1]
Scientific Advisory Group for Emergencies
- Full article: Scientific Advisory Group for Emergencies
- Full article: Scientific Advisory Group for Emergencies
Vallance, as chair of Scientific Advisory Group for Emergencies, was one of very few members who was publicly named. He stated in a letter to the UK parliament in April 2020 that the decision not to disclose its membership was based on advice from the Centre for the Protection of National Infrastructure.[2]
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.
